Filtered By:
Infectious Disease: Pandemics
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 1816 results found since Jan 2013.
The COVID-19 virus mutated to outsmart key antibody treatments. Better ones are coming
In 2020, as the COVID-19 pandemic raged and other effective drugs were elusive, monoclonal antibodies (mAbs) emerged as a lifesaving treatment. But now, 3 years later, all the approvals for COVID-19–fighting antibodies have been rescinded in the United States, as mutations of the SARS-CoV-2 virus have left the drugs—which target parts of the original virus—ineffective.
Researchers around the globe are now trying to revive antibody treatments by redesigning them to take aim at targets that are less prone to mutation. “There are new approaches that present a much more challenging task for the virus to evade,” ...
Source: ScienceNOW - May 24, 2023 Category: Science Source Type: news
COVID-19 Incidence and Disease Course Among Patients at an Allergy Department
CONCLUSION: The cumulative COVID-19 incidence in patients from the allergy cohort was higher compared with the general Dutch population, but similar compared with household members. There was no difference in symptoms, disease duration, or hospitalization rate between the allergy cohort and their household members.PMID:37207194 | PMC:PMC10189845 | DOI:10.1177/27534030231172391
Source: Adv Data - May 19, 2023 Category: Epidemiology Authors: Louise E van der Aa Inge S van Egmond Martijn van der Sluijs A A Sophie den Otter Nadie H M Bosmans Sabine E van Beek Angela Hartman Niels A D Guchelaar Paul L A van Daele Maurits S van Maaren P Martin van Hagen Maud A W Hermans Saskia M Rombach Source Type: research
Trust and Virtual Communication During the COVID pandemic for adults with asthma from low income neighborhoods: What Have We Learned?
Low-income and marginalized adults disproportionately bear the burden of poor asthma outcomes. One consequence of the structural racism which preserves these inequities is decreased trust in government and healthcare institutions.
Source: Journal of Allergy and Clinical Immunology - May 11, 2023 Category: Allergy & Immunology Authors: Andrea J. Apter, Tyra Bryant-Stephens, Hami Park, Heather Klusaritz, Xiaoyan Han, Knashawn H. Morales Source Type: research
Trust and virtual communication during the COVID-19 pandemic for adults with asthma from low-income neighborhoods: What have we learned?
Low-income and marginalized adults disproportionately bear the burden of poor asthma outcomes. One consequence of the structural racism that preserves these inequities is decreased trust in government and health care institutions.
Source: Journal of Allergy and Clinical Immunology - May 11, 2023 Category: Allergy & Immunology Authors: Andrea J. Apter, Tyra Bryant-Stephens, Hami Park, Heather Klusaritz, Xiaoyan Han, Knashawn H. Morales Source Type: research
NIH restarts bat virus grant suspended 3 years ago by Trump
Three years after then-President Donald Trump pressured the National Institutes of Health (NIH) to suspend a research grant to a U.S. group studying bat coronaviruses with partners in China, the agency has restarted the award.
The new 4-year grant is a stripped-down version of the original grant to the EcoHealth Alliance, a nonprofit research organization in New York City, providing $576,000 per year. That 2014 award included funding for controversial experiments that mixed parts of different bat viruses related to severe acute respiratory syndrome (SARS), the coronavirus that sparked a global outbreak in 2002–04, a...
Source: ScienceNOW - May 8, 2023 Category: Science Source Type: news
CDC Says Walensky Will Step Down as Director in June CDC Says Walensky Will Step Down as Director in June
CDC Director Rochelle Walensky, MD, MPH, will step down from her position at the end of June, 2 ½ years after assuming the role during the height of the COVID-19 pandemic.WebMD Health News
Source: Medscape Allergy Headlines - May 8, 2023 Category: Allergy & Immunology Tags: Infectious Diseases News Source Type: news
Global Disease Burden and Attributable Risk Factor Analysis of Asthma in 204 Countries and Territories From 1990 to 2019
CONCLUSIONS: Globally, the asthma incidence has increased since 1990. The greatest asthma burden is borne by the low-middle SDI region. The 2 groups that need special attention are those under 9 years old and those over 60 years old. Targeted strategies are needed to reduce the asthma burden based on geographic and sex-age characteristics. Our findings also provide a platform for further investigation into the asthma burden in the era of COVID-19.PMID:37153981
Source: Allergy, Asthma and Immunology Research - May 8, 2023 Category: Allergy & Immunology Authors: Hailing Liu Jing Zhang Li Liu Guoli Lian Ruiming Shi Man Xu Juan Yang Xiaohong Liu Source Type: research
Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study
CONCLUSION: The prevalence rates of asthma and fatalities from COVID-19 showed a gradual reduction throughout the pandemic in Mexico.PMID:37141944 | PMC:PMC10154243 | DOI:10.1016/j.anai.2023.04.028
Source: Annals of Allergy, Asthma and Immunology - May 4, 2023 Category: Allergy & Immunology Authors: Mart ín Bedolla-Barajas Jaime Morales-Romero Mart ín Robles-Figueroa Tonatiuh Delgado-Figueroa Source Type: research
